Fengshuo Liu

7PUBLICATIONS
48CO-AUTHORS
Molecular targetsInnate immunityModelling and simulationCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|May 28, 2026
ICAM1high Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration.

|May 10, 2026
iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalk.

|Jan 03, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|Jun 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|Feb 20, 2025
Invasion and metastasis in cancer: molecular insights and therapeutic targets.

Yongxing Li, Fengshuo Liu, Qingjin Cai

Pageof 2

Frequent Collaborators

5 joint publications

Xiang H-F Zhang

3 joint publications

Yang Gao

3 joint publications

Hilda L Chan

3 joint publications

Jeffrey M Rosen